Heart and cancer: cardio-oncology

被引:0
作者
Michel, Lars [1 ]
Rassaf, Tienush [1 ,2 ]
机构
[1] Univ Klinikum Essen, Klin Kardiol & Angiol, Westdeutsch Herz & Gefasszentrum, Essen, Germany
[2] Univ Klinikum Essen, Klin Kardiol & Angiol, Westdeutsch Herz & Gefasszentrum, Hufelandstr 55, D-45147 Essen, Germany
关键词
Cardiovascular diseases; Cancer; Anthracyclines; Cardiotoxicity; Reverse cardio-oncology; TUMOR-GROWTH; FAILURE;
D O I
10.1007/s00059-024-05232-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases and cancer have a complex relationship and show a reciprocal linkage and influence. Mutual risk factors, demographic changes and increasing multimorbidity result in an increase in the incidence of both diseases. Advances in oncological and cardiological treatment lead to a further increase in patients with cured or chronic diseases as a relevant comorbidity. The induction of cardiovascular side effects by cancer therapies leads to increased cardiovascular morbidity and mortality in cancer patients. Recent data also show that cardiovascular disease, through various factors, can also promote the development and progression of cancer. An understanding of the interrelationship between cardiovascular diseases and cancer can be seen as a major medical challenge for the future. To this end, scientific, structural, clinical and educational interfaces between cardiology and oncology are essential. This article outlines the complex relationships between cardiovascular diseases and cancer and defines current and future challenges for the best possible care of affected patients.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 30 条
[1]   Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease [J].
Aboumsallem, Joseph Pierre ;
Moslehi, Javid ;
de Boer, Rudolf A. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (02)
[2]   Early Cardiac Remodeling Promotes Tumor Growth and Metastasis [J].
Avraham, Shimrit ;
Abu-Sharki, Soraya ;
Shofti, Rona ;
Haas, Tali ;
Korin, Ben ;
Kalfon, Roy ;
Friedman, Tom ;
Shiran, Avinoam ;
Saliba, Walid ;
Shaked, Yuval ;
Aronheim, Ami .
CIRCULATION, 2020, 142 (07) :670-683
[3]   Linking Heart Failure to Cancer: Background Evidence and Research Perspectives [J].
Bertero, Edoardo ;
Canepa, Marco ;
Maack, Christoph ;
Ameri, Pietro .
CIRCULATION, 2018, 138 (07) :735-742
[4]   Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies [J].
Dempsey, Naomi ;
Rosenthal, Amanda ;
Dabas, Nitika ;
Kropotova, Yana ;
Lippman, Marc ;
Bishopric, Nanette H. .
BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) :21-36
[5]  
( DESTATIS) SB, 2022, MITTEN DEMOGRAPHSICH
[6]  
( DESTATIS) SB, 2021, TODESURSACHEN DEUTSC
[7]   Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement [J].
Herrmann, Joerg ;
Lenihan, Daniel ;
Armenian, Saro ;
Barac, Ana ;
Blaes, Anne ;
Cardinale, Daniela ;
Carver, Joseph ;
Dent, Susan ;
Ky, Bonnie ;
Lyon, Alexander R. ;
Lopez-Fernandez, Teresa ;
Fradley, Michael G. ;
Ganatra, Sarju ;
Curigliano, Giuseppe ;
Mitchell, Joshua D. ;
Minotti, Giorgio ;
Lang, Ninian N. ;
Liu, Jennifer E. ;
Neilan, Tomas G. ;
Nohria, Anju ;
O'Quinn, Rupal ;
Pusic, Iskra ;
Porter, Charles ;
Reynolds, Kerry L. ;
Ruddy, Kathryn J. ;
Thavendiranathan, Paaladinesh ;
Valent, Peter .
EUROPEAN HEART JOURNAL, 2022, 43 (04) :280-+
[8]  
Herzstiftung D, 2021, HERZBERICHT 2021
[9]  
Krebsregisterdaten) RKIZf, 2023, KREBS DEUTSCHLAND 20
[10]   Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council [J].
Lancellotti, Patrizio ;
Suter, Thomas M. ;
Lopez-Fernandez, Teresa ;
Galderisi, Maurizio ;
Lyon, Alexander R. ;
Van der Meer, Peter ;
Solal, Alain Cohen ;
Zamorano, Jose-Luis ;
Jerusalem, Guy ;
Moonen, Marie ;
Aboyans, Victor ;
Bax, Jeroen J. ;
Asteggiano, Riccardo .
EUROPEAN HEART JOURNAL, 2019, 40 (22) :1756-1763